Innovate.
Accelerate.
Change Lives.

Conduit Pharmaceuticals Limited (“Conduit”) is led by highly experienced pharma executives, Dr. Freda Lewis-Hall and Dr. David Tapolczay, to fund the development of successful deprioritized clinical assets licensed from large pharmaceutical companies.

Press Releases

See all

Events

See all

Subscribe

info@conduitpharma.com

Email Alerts